Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yunnan Bosar Biotechnology Co., Ltd. (also known as Yunnan Boshiao Biotechnology) is a high-tech modern biotechnology company founded in 2014 and based in Kunming, Yunnan Province, China. The company specializes in the research, development, production, and sales of feed-grade, industrial-grade, and food-grade biological preparations, including feed enzymes (such as cellulases, pectinases, mannanases, and proteases), probiotics (beneficial microorganisms), and yeast protein selenium. Yunnan Bosar Biotechnology has developed an innovative, intelligent post-addition system that allows the precise, damage-free application of proteases and microecological preparations to extruded feed, preserving their biological activity. The company maintains long-term research collaborations with prominent academic institutions, including China Agricultural University, South China Agricultural University, and Yunnan University, to advance its microbial fermentation and enzyme technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yunnan Bosar Biotechnology.